NCT07809880

Brief Summary

Investigators invite you to the research titled "Evaluation of Serum Electrolyte Imbalance in Geriatric Patients Undergoing Brain Surgery: A Prospective Randomized Observational Study" conducted by Specialist Nurse Tülin KURT ALKAN. Before participant decide whether or not to participate in this research, you need to know why and how the research will be conducted. For this reason, it is of great importance to read and understand this form. Take the time to read the information below carefully. If participant want, discuss this information with participant' family and/or relatives. If there are things that participant do not understand and are not clear to participant, or if participant want more information, please ask investigators. For the purpose of the research, questions such as the patient's age, gender, chronic diseases, mechanism of injury, surgical procedure will be asked. Other data include Glaskow Coma Scale score, ASA class, cardiopulmonary resuscitation history, patient's day of stay in intensive care, number of intubated patient days, blood sugar, alanine aminotransferase, aspartate aminotransferase, urea, creatinine, serum sodium, serum potassium, serum calcium, serum chloride, serum magnesium, serum phosphorus, albumin value, as well as from participant's file/systemic data such as patient's follow-up it will be taken. According to the course of the interview, it will take about 5 minutes. With the information to be obtained in line with the interviews to be held with participant, "Evaluation of Serum Electrolyte Imbalances in Geriatric Patients Undergoing Brain Surgery: A Prospective Randomized Observational Study" will be attempted. Participation in the research is completely voluntary. If participants want to at any time while the research is ongoing, participants can leave the research provided that participants inform the responsible researcher. Participants answering the questionnaire will be interpreted as giving your consent to participate in the research. The information received from participant during the research will be kept by the researcher and the collected data will be used only for scientific purposes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 25, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2025

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

September 9, 2026

Completed
Last Updated

September 9, 2026

Status Verified

September 1, 2026

Enrollment Period

1 month

First QC Date

February 21, 2025

Last Update Submit

September 8, 2026

Conditions

Keywords

NursingGeriatric patientsSerum concentrationsBrain injury traumatic severe

Outcome Measures

Primary Outcomes (1)

  • The researcher's data form checklist

    Data Form: The researcher's data form consisted of the sociodemographic characteristics of the participants (age, gender, chronic diseases, mechanism of injury) and clinical characteristics (surgical procedure, Glasgow Coma Scale score, ASA class, history of cardiopulmonary resuscitation, number of intubation days) of patients. Also, serum electrolyte values were monitored (blood glucose, alanine aminotransferase, aspartate aminotransferase, urea, creatinine, serum sodium, potassium, calcium, chloride, magnesium, serum phosphorus, and albumin). The patients and their relatives were interviewed after ethical approval and the necessary permissions from the institution where the study was conducted. The purpose and scope of the study were explained, and they were invited to participate. Their written consent was obtained. Once the patients were hospitalized in the neurology intensive care unit, the Personal Information Form was completed and recorded over five days.

    August and October 2024

Secondary Outcomes (1)

  • Glasgow Coma Scale (GCS)

    August-October 2024

Study Arms (2)

Surgery Group

30 neurosurgical patients

Non-Surgery Group

30 neurological patients

Eligibility Criteria

Age65 Years - 92 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

The study group included geriatric patients: with and without surgery. G\*Power software (version 3.1.9.7) was used for power analysis and 60 patients were included in the study. To ensure the relevance of the data, the study included patients within the first 24 hours after trauma and the first 24 hours of hospitalization. Neurological patients with or without neurosurgery, aged 65 years and older, who volunteered to participate were included in the study. Patients with chronic renal failure and heart failure using diuretics were not included in the study.

You may qualify if:

  • To ensure the relevance of the data, the study included patients within the first 24 hours after trauma and the first 24 hours of hospitalization. Neurological patients with or without neurosurgery, aged 65 years and older, who volunteered to participate were included in the study.

You may not qualify if:

  • Patients with chronic renal failure and heart failure using diuretics were not included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zonguldak Atatürk State Hospital

Zonguldak, Center, 67030, Turkey (Türkiye)

Location

Related Links

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 21, 2025

First Posted

September 9, 2026

Study Start

August 25, 2024

Primary Completion

September 25, 2024

Study Completion

October 25, 2024

Last Updated

September 9, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

Age Glasgow coma scale ASA class Number of intubated days Gender Mechanism of injury Surgical procedure Resuscitation Chronically ill Electrolyte values

Shared Documents
CSR
Time Frame
in 2025
Access Criteria
Scientists

Locations